Three thrombolytic drugs can now be used to promote the recanalisation of acutely occluded coronary arteries, restoring blood flow to ischaemic areas of myocardium, limiting damage and improving the prognosis:1 streptokinase, alteplase (Actilyse - Boehringer Ingelheim) and anistreplase (Eminase - Beecham). This article compares the last two, following our review of recent trials of streptokinase and alteplase.2
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.